The application of probiotics in cancer

British Journal of Nutrition

Volumn 98, Issue SUPPL. 1, 2007, Pages

  de Moreno de LeBlanc, Alejandra ^a   Matar, Chantal ^b   Perdigón, Gabriela ^a,c  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSITÉ DE MONCTON   (Canada)

^c UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Breast cancer; Colon cancer; Intestine; Probiotics

Indexed keywords

BIOLOGICAL FACTOR; CYTOKINE; DIMETHYLHYDRAZINE; IMMUNOGLOBULIN A; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; YOGHURT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CACHEXIA; CANCER INHIBITION; CANCER PREVENTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLON CANCER; CONFERENCE PAPER; DIET THERAPY; ENVIRONMENTAL FACTOR; GASTROINTESTINAL DISEASE; GROWTH INHIBITION; HEREDITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; LACTIC ACID BACTERIUM; LACTOBACILLUS HELVETICUS; MAMMARY GLAND; NONHUMAN; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; COLONIC NEOPLASMS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; PROBIOTICS;

EID: 35148813459     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507839602     Document Type: Conference Paper

References (24)

1. Perdigón G, Valdez JC & Rachid M (1998) Antitumour activity of yogurt: Study of possible immune mechanisms. Journal of Dairy Research 65: 129-138.
2. Isaacson P (1982) Immunoperoxidase study of the secretory immunoglobulin system and lysozyme in normal and diseased gastric mucosa. Gut 23, 578-588.
3. Prescott SM & Fitzpatrick FA (2000) Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470, M69-M78.
4. Feghali CA & Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2, d12-d26.
5. Weitzman SA & Gordon LI (1990) Inflammation and cancer: Role of phagocytegenerated oxidants in carcinogenesis. Blood 76, 655-663.
6. Fulton AM (1984) In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res 44, 2416-2420.
7. Lala PK, Parhar RS & Singh P (1986) Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. Cell Immunol 99, 108-118.
8. Reddy BS, Maruyama H & Kelloff G (1987) Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-nflammatory drug, during different stages of rat colon tumor development. Cancer Res 47, 5340-5346.
9. de Moreno de LeBlanc A, Valdéz J & Perdigón G (2004) Regulatory effect of yoghurt on intestinal inflammatory immune response. Eur J Inflamm 2(1), 21-61.
10. Perdigón G, de Moreno de LeBlanc A, Valdez JC & Rachid M (2002) Role of yoghurt in the prevention of colon cancer. Eur J Clin Nutr 56, Suppl. 3, S65-S68.
11. Bogdan C. Rollinghoff M & Diefenbach A (2000) The role of nitric oxide in innate immunity. Immunol Rev 173, 17-26.
12. Matar C, LeBlanc JG, Martin L & Perdigón G (2003) Biologically Active Peptides Released from Fermented Milk: Role and Functions. In Handbook of Fermented Functional Foods, pp. 177-201 [T Farnworth, editor]. Boca Raton, FL, USA: CRC Press.
13. LeBlanc JG, Matar C. Valdez JC, LeBlanc J & Perdigón G (2002) Immunomodulatory effetcs of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Res 85, 2733-2742.
14. Matar C, Amiot J, Savoie L & Goulet J (1996) The effect of milk fermentation by Lactobacillus helveticus on the release of peptides during in vitro digestion. J Dairy Sci 79, 971-979.
15. Matar C, Nadathur SS, Bakalinsky AT & Goulet J (1997) Anti-mutagenic effects of milk fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68, 601-609.
16. Matar C, Valdez JC, Medina M, Rachid M & Perdigón G (2001) Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J Dairy Res 68, 601-609.
17. de Moreno de LeBlanc A, Matar C, LeBlanc N & Perdigón G (2005) Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Research 7, 477-486.
18. Purohit A, Newman SP & Reed MJ (2002) The role of cytokines in regulating estrogen synthesis: Implications for the etiology of breast cancer. Breast Cancer Res 4(2), 65-69.
19. Urban JL, Shepard HM, Rothstein JL & Sugarman BJ (1986) Tumour necrosis factor: A potent effector molecule for tumour cell killing by activated macrophages. Proc Natl Acad Sci USA 83, 5233-5237.
20. Ferrarini M, Ferrero E, Dagna LPA & Zocchi MRHuman γδ T cells (2002) a nonredundant system in the immune-surveillance against cancer. Trends Immunol 23, 14-18.
21. Bingle L, Brown NJ & Lewis CE (2000) The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol 196, 254-265.
22. Brandtzaeg P & Pabst R (2004) Let's go mucosal: Communication on slippery ground. Trends Immunol 25, 570-577.
23. de Moreno de LeBlanc A, Matar C, Thériault G & Perdigón G (2005) Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 210, 349-358.
24. de Moreno de LeBlanc A & Perdigón G (2004) Yoghurt feeding inhibits promotion and progression of experimental colorectal cancer. Med Sci Monit 10(4), Br96-B104.